SANTINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 503
EU - Europa 203
AS - Asia 113
SA - Sud America 16
AF - Africa 9
Totale 844
Nazione #
US - Stati Uniti d'America 503
SG - Singapore 63
SE - Svezia 51
IT - Italia 49
IE - Irlanda 46
CN - Cina 34
UA - Ucraina 19
BR - Brasile 13
GB - Regno Unito 12
DE - Germania 10
IN - India 7
FR - Francia 6
CI - Costa d'Avorio 5
FI - Finlandia 3
VN - Vietnam 3
AT - Austria 2
DK - Danimarca 2
ID - Indonesia 2
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
IQ - Iraq 1
KG - Kirghizistan 1
KR - Corea 1
MA - Marocco 1
NO - Norvegia 1
SN - Senegal 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 844
Città #
Chandler 86
Ashburn 56
Dublin 46
Fairfield 44
Singapore 29
Boardman 28
New York 28
Jacksonville 25
Lawrence 20
Princeton 20
Houston 16
Turin 16
San Diego 13
Seattle 13
Wilmington 12
Washington 10
Woodbridge 9
Beijing 8
Cambridge 7
London 6
Abidjan 5
Ann Arbor 5
San Mateo 5
Macerata 4
Dallas 3
Los Angeles 3
Guangzhou 2
Hanoi 2
Helsinki 2
Marche 2
Mountain View 2
Palermo 2
Pune 2
Redwood City 2
Vienna 2
Baghdad 1
Bishkek 1
Canto do Buriti 1
Casablanca 1
Casalbordino 1
Chiswick 1
Clifton 1
Contagem 1
Cornélio Procópio 1
Curitiba 1
Dakar 1
Dhaka 1
Falkenstein 1
Hangzhou 1
Ibimirim 1
Jiaxing 1
Jinhua 1
Johannesburg 1
Kilburn 1
La Paz 1
Lages 1
Luoyang 1
Maceió 1
Miami Beach 1
Nuremberg 1
Paris 1
Prague 1
Quito 1
Ribeirão das Neves 1
Rio Largo 1
San Francisco 1
Santiago 1
Santo André 1
Shanghai 1
Shijiazhuang 1
Southwark 1
São Paulo 1
São Sebastião do Paraíso 1
Tallinn 1
Tianjin 1
Tunis 1
Vinnytsia 1
Volta Redonda 1
Wuhu 1
Xi'an 1
Zhengzhou 1
Totale 581
Nome #
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 78
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) 72
Prognostic vs predictive molecular biomarkers in colorectal cancer: Is KRAS and BRAF wild type status required for anti-EGFR therapy? 65
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 64
Role of STAT3 pathway in genitourinary tumors 59
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 58
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 52
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 48
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623 44
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 37
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 36
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 35
Germline copy number variation in the YTHDC2 gene: Does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 35
Driver mutations and differential sensitivity to targeted therapies: A new approach to the treatment of lung adenocarcinoma 33
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 33
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 30
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: A retrospective analysis 29
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients 29
Predicting efficacy and toxicity in the era of targeted therapy: Focus on anti-EGFR and anti-VEGF molecules 28
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: There is a sense in antisense? 25
Totale 890
Categoria #
all - tutte 8.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 5 0 5 3 6 6
2020/202193 9 6 17 0 8 7 8 8 11 8 9 2
2021/2022134 4 5 4 0 1 3 0 4 35 16 41 21
2022/2023273 20 28 34 10 15 33 1 12 68 1 43 8
2023/2024196 26 5 19 24 29 59 2 8 0 1 14 9
2024/2025146 29 24 5 10 23 55 0 0 0 0 0 0
Totale 890